Sangamo Therapeutics
SGMO
#8834
Rank
A$0.20 B
Marketcap
A$0.54
Share price
0.50%
Change (1 day)
-66.29%
Change (1 year)

Sangamo Therapeutics (SGMO) - P/B ratio

P/B ratio as of March 2026 : 23.2

According to Sangamo Therapeutics 's latest financial reports the company has a price-to-book ratio of 4.39803.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Sangamo Therapeutics - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-3123.60.78%
2024-12-3123.51917.96%
2023-12-311.16-33.37%
2022-12-311.74-40.07%
2021-12-312.91-34.41%
2020-12-314.4497.84%
2019-12-312.24-29.78%
2018-12-313.19-56.7%
2017-12-317.38366.44%
2016-12-311.58-52.62%
2015-12-313.34-34.34%
2014-12-315.08-28.44%
2013-12-317.1044.56%
2012-12-314.91164.22%
2011-12-311.86-65.49%
2010-12-315.3945.24%
2009-12-313.7144.14%
2008-12-312.57-64.63%
2007-12-317.2853.27%
2006-12-314.7545.76%
2005-12-313.26-30.43%
2004-12-314.6853.23%
2003-12-313.06122.63%
2002-12-311.37

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.20-68.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
20.8-10.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
1.48-93.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
1.50-93.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
8.40-63.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
5.52-76.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
53.2 129.90%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
1.85-92.02%๐Ÿ‡บ๐Ÿ‡ธ USA